project id: TCGA-ESCA; case submitter id: TCGA-R6-A6L6; source center: 23; state: released; a260 a280 ratio: 2.04; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.62; rna integrity number: 7.6; age at index: 68; days to birth: -25092; days to death: 214; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1942; year of death: 2010; age at diagnosis: 25092; ajcc clinical m: M1; ajcc clinical n: NX; ajcc clinical stage: Stage IV; ajcc clinical t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: No; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 1259; days to sample procurement: 0; initial weight: 1.0; sample id: 58ac6453-f187-4676-a8fe-054284f1a673; sample submitter id: TCGA-R6-A6L6-01B; portion id: b316ee9a-ba95-4421-a1db-434a9611576c; portion submitter id: TCGA-R6-A6L6-01B-11; slide id: 8b0a74e3-35c0-49ae-b130-d956ab6afc83; slide submitter id: TCGA-R6-A6L6-01Z-00-DX1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 40.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;